Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.63 |
| ▸ | MEN1 | O00255 | 3/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.62 |
| ▸ | GAA | P10253 | 3/20 | 0.62 |
| ▸ | POLB | P06746 | 1/20 | 0.62 |
| ▸ | GFER | P55789 | 1/20 | 0.62 |
| ▸ | EPHX2 | P34913 | 7/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | ESR1 | P03372 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | XBP1 | P17861 | 1/20 | 0.47 |
| ▸ | CNR2 | P34972 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24559531 | 1.00 | LMNA (0.63) | LMNAALDH1A1MEN1KMT2AGAA | |
| SCHEMBL22644196 | 1.00 | LMNA (0.63) | LMNAALDH1A1MEN1KMT2AGAA | |
| SCHEMBL20789695 | 0.91 | LMNA (0.50) | LMNAALDH1A1MEN1KMT2AGAA | |
| SCHEMBL10296837 | 0.89 | ALDH1A1 (0.52) | LMNAALDH1A1MEN1KMT2AGAA | |
| SCHEMBL2763437 | 0.88 | LMNA (0.77) | LMNAALDH1A1MEN1KMT2AGAA | |
| SCHEMBL649556 | 0.87 | ESR1 (0.60) | LMNAALDH1A1MEN1KMT2AGAA | |
| SCHEMBL16364512 | 0.87 | ESR1 (0.60) | LMNAALDH1A1MEN1KMT2AGAA | |
| SCHEMBL20648576 | 0.86 | MEN1 (0.49) | LMNAALDH1A1MEN1KMT2AGAA | |
| SCHEMBL28789384 | 0.85 | ESR1 (0.58) | LMNAALDH1A1MEN1KMT2AGAA | |
| SCHEMBL17660048 | 0.85 | EPHX2 (0.47) | LMNAALDH1A1MEN1KMT2AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1130 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117625082-B | PID-resistant functional auxiliary agent preparation method of EVA adhesive film and EVA adhesive film | 苏州易昇光学材料股份有限公司 | 2024-09-06 | — | — | CN | claimed |
| CN-117624527-B | Antioxidant Huang Chuji, preparation method thereof and EVA adhesive film | 苏州易昇光学材料股份有限公司 | 2024-06-21 | — | — | CN | claimed |
| CN-117801691-B | Anti-precipitation EPE co-extrusion packaging adhesive film | 苏州易昇光学材料股份有限公司 | 2024-06-18 | — | — | CN | claimed |
| CN-114181091-B | Synthesis process of adamantane triphenylamine | 维思普新材料（苏州）有限公司 | 2024-06-14 | — | — | CN | claimed |
| CN-114672147-B | Adamantane-containing random anion exchange membrane and preparation method thereof | 华侨大学 | 2024-05-14 | — | — | CN | claimed |
| CN-117625082-A | PID (potential induced degradation) -resistant functional auxiliary agent, preparation method thereof and EVA (ethylene-vinyl acetate) adhesive film | 苏州易昇光学材料股份有限公司 | 2024-03-01 | — | — | CN | claimed |
| CN-117624527-A | Anti-oxidation Huang Chuji, preparation method thereof and EVA adhesive film | 苏州易昇光学材料股份有限公司 | 2024-03-01 | — | — | CN | claimed |
| CN-117467249-A | Anti-irradiation fruit fresh-keeping film and preparation method thereof | 台州鸿博辐照科技有限公司 | 2024-01-30 | — | — | CN | claimed |
| CN-109923475-B | Photosensitive coloring composition, cured product, coloring spacer and image display device | 三菱化学株式会社 | 2022-12-02 | — | — | CN | claimed |
| CN-114685828-A | Adamantyl block type anion exchange membrane and preparation method thereof | 华侨大学 | 2022-07-01 | — | — | CN | claimed |
| EP-1398401-A2 | Method for creating diamond | HOKKAIDO UNIVERSITY (JP) | 2004-03-17 | — | — | EP | claimed |
| US-20030187307-A1 | Hydroxyphenyl adamantanes and process for the production of the same | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2003-10-02 | — | — | US | claimed |
| EP-1336597-A1 | Hydroxyphenyl adamantanes and process for the production of the same | Honshu Chemical Industry Co., Ltd. (JP) | 2003-08-20 | — | — | EP | claimed |
| EP-1327260-A2 | SIMPLIFIED METHOD TO PRODUCE NANOPOROUS SILICON-BASED FILMS | Honeywell International Inc. (US) | 2003-07-16 | — | — | EP | claimed |
| US-20030077918-A1 | Simplified method to produce nanoporous silicon-based films | WU HUI-JUNG (US) | 2003-04-24 | — | — | US | claimed |
| US-6495479-B1 | COATING WITH SUCH AS TETRAACETOXYSILANE AND A POROGEN, AGING OR CONDENSING IN PRESENCE OF WATER AND HEATING THE GELLED FILM | HONEYWELL INTERNATIONAL, INC. | 2002-12-17 | — | — | US | claimed |
| WO-2001086709-A2 | SIMPLIFIED METHOD TO PRODUCE NANOPOROUS SILICON-BASED FILMS | HONEYWELL INTERNATIONAL INC. (US) | 2001-11-15 | — | — | WO | claimed |
| EP-1103566-A1 | Nickel-based catalyst and gas phase polymerization process for polybutadiene | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 2001-05-30 | — | — | EP | claimed |
| CN-1296984-A | Nickel-based catalyst for producing polybutadiene and gas-phase polymerization process thereof | UNION CARBIDE CHEM PLASTIC (US) | 2001-05-30 | — | — | CN | claimed |
| US-5851513-A | Antiplaque oral composition and method | COLGATE PALMOLIVE COMPANY (US) | 1998-12-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030187307-A1 | Hydroxyphenyl adamantanes and process for the production of the same | CYP8B1, DHPS, P4HA1 | LMNA 674/4885ALDH1A1 118/4885MEN1 1025/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.